TrademarkDir
PHARMTRACE
LIVE

Serial Number

79069710

Owner

Pharmtrace klinische Entwicklung GmbH

Attorney

Andrew R. Silverman

Filing Date

Feb 11, 2009

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

PHARMTRACE Trademark

Serial Number: 79069710 • Registration: 3799744

PHARMTRACE is a trademark filed by Pharmtrace klinische Entwicklung GmbH on February 11, 2009. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Pharmtrace klinische Entwicklung GmbH (2 trademarks)

Berlin 10117 , DE

Entity Type: 16

Trademark Details

Filing Date

February 11, 2009

Registration Date

June 8, 2010

Published for Opposition

March 23, 2010

Goods & Services

[ Education services, namely, providing classes, seminars, workshops and training in the fields of drug development, life cycle management, clinical research and development,diagnostic imaging and molecular medicine; provision of training, namely, subject-specific further training in the field of clinical research and development, diagnostic imaging and molecular medicine; organization and arranging of seminars; entertainment, namely,organization of exhibitions for cultural or educational purposes and organizing community sporting and cultural events ]

[ Advertising and advertisement services; marketing services regarding clinical trials, namely, business consulting services with respect to marketing clinical trials; providing advertising, marketing and promotional services for the pharmaceutical and medical products of others, namely, marketing services regarding pharmaceutical products by means of promoting clinical trial data, including diagnostic imaging procedures; business management; business administration; providing office functions ]

[ Medical and veterinary services; hygienic and beauty care for human beings and animals; advisory services relating to pharmaceutical preparations ]

Scientific and technological services and research and design relating thereto, namely, scientific research and development, and providing medical and scientific research information in the fields of pharmaceuticals, clinical trials, drug development, life cycle management, clinical research and development, diagnostic imaging and molecular medicine; industrial analysis and research services in the fields of pharmaceuticals, clinical trials, drug development, life cycle management, clinical research and development, diagnostic imaging and molecular medicine; design and development of computer hardware and software

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 20, 2023 FINP
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Dec 9, 2022 INNA
GENERIC MADRID TRANSACTION SENT TO IB
Dec 7, 2022 XXSS
GENERIC MADRID TRANSACTION CREATED
Dec 7, 2022 XXCR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
May 1, 2021 INPR
FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 23, 2021 FINT
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Dec 19, 2020 OPNX
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Sep 1, 2020 NA71
REGISTERED-SEC.71 ACCEPTED
Sep 1, 2020 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 1, 2020 APRE
TEAS SECTION 71 RECEIVED
Jun 4, 2020 ES71
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 12, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 12, 2020 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 12, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 12, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 12, 2020 COAR
INTERNATIONAL REGISTRATION RENEWED
Aug 23, 2019 RNWL
REFUSAL PROCESSED BY IB
Jul 18, 2019 RFNT
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Jun 8, 2019 REM4
PARTIAL INVALIDATION PROCESSED BY THE IB
Dec 28, 2017 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Sep 28, 2017 INPS
INVALIDATION PROCESSED
Sep 28, 2017 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Sep 27, 2017 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Jan 28, 2017 NA71
REGISTERED - PARTIAL SEC 71 ACCEPTED
Jan 27, 2017 71.P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 19, 2017 APRE
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Jan 10, 2017 EROP
POST REGISTRATION ACTION MAILED - SEC.71
Jul 13, 2016 PR71
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jul 11, 2016 APRE
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 3, 2016 TCCA
TEAS SECTION 71 RECEIVED
Jun 3, 2016 ES71
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 12, 2013 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 9, 2010 FICS
FINAL DISPOSITION PROCESSED
Sep 9, 2010 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 8, 2010 FICR
REGISTERED-PRINCIPAL REGISTER
Jun 8, 2010 R.PR
PUBLISHED FOR OPPOSITION
Mar 23, 2010 PUBO
NOTICE OF PUBLICATION
Mar 3, 2010 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 17, 2010 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 17, 2010 CNSA
AMENDMENT FROM APPLICANT ENTERED
Jan 20, 2010 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 20, 2010 CRFA
ASSIGNED TO LIE
Jan 20, 2010 ALIE
PAPER RECEIVED
Jan 12, 2010 MAIL
REFUSAL PROCESSED BY IB
Sep 19, 2009 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 15, 2009 RFCS
REFUSAL PROCESSED BY MPU
Jul 15, 2009 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 15, 2009 RFCR
NON-FINAL ACTION WRITTEN
Jul 14, 2009 CNRT
APPLICATION FILING RECEIPT MAILED
Jul 14, 2009 MAFR
ASSIGNED TO EXAMINER
Jul 10, 2009 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 10, 2009 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 9, 2009 REPR

Related Trademarks

More from this Owner

PHARMTRACE

PHARMTRACE